EUVIMEDEUVIMED entdecken
Crossref

Nationwide Geographic Access to Subcutaneous Anti-Amyloid Alzheimer Disease Therapy Infrastructure

Fred B Ketchum, Cassie Sanford, Will Buckingham, Amy J H Kind, W Ryan Powell

JAMA Neurology · 16.11.2026

DOI: 10.1001/jamaneurol.2026.4253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Neurology, online erschienen am 16.11.2026. Verfasst von Fred B Ketchum und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This cross-sectional study describes how geographic availability of the minimum health care infrastructure required for subcutaneous therapy for Alzheimer disease treatment varies by age and location across the US.

Autor:innen und Institutionen

  • Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison.
  • Center for Heath Disparities Research, University of Wisconsin School of Medicine and Public Health, Madison.
  • Department of Medicine, Geriatrics Division, University of Wisconsin School of Medicine and Public Health, Madison.
  • Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison.

Zitieren

APA

Ketchum, F. B., Sanford, C., Buckingham, W., Kind, A. J. H., & Powell, W. R. (2026). Nationwide Geographic Access to Subcutaneous Anti-Amyloid Alzheimer Disease Therapy Infrastructure. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2026.4253

Vancouver

Ketchum FB, Sanford C, Buckingham W, Kind AJH, Powell WR. Nationwide Geographic Access to Subcutaneous Anti-Amyloid Alzheimer Disease Therapy Infrastructure. JAMA Neurology. 2026. doi:10.1001/jamaneurol.2026.4253

BibTeX
@article{Ketchum2026,
  author = {Ketchum, Fred B and Sanford, Cassie and Buckingham, Will and Kind, Amy J H and Powell, W Ryan},
  title = {Nationwide Geographic Access to Subcutaneous Anti-Amyloid Alzheimer Disease Therapy Infrastructure},
  journal = {JAMA Neurology},
  year = {2026},
  doi = {10.1001/jamaneurol.2026.4253}
}
Kostenlos starten →